---
type: "Bill"
title: "Clinical Research Pharmacies and Clinical Trials - Permits and Ownership"
description: "Clinical Research Pharmacies and Clinical Trials - Permits and Ownership"
jurisdiction: "us/states/md"
legislature: "Maryland General Assembly"
session: "2026"
identifier: "SB 778"
citation: "Maryland SB 778 (2026)"
classification: ["bill"]
subjects: []
status: "enacted"
primary_sponsors: ["Feldman"]
version_count: 3
action_count: 13
vote_count: 2
first_action: "2026-02-06"
last_action: "2026-04-28"
source: "openstates"
source_identifier: "ocd-bill/498ecf74-d8cc-4270-abfc-89c1610eec22"
source_url: "http://mgaleg.maryland.gov/mgawebsite/Legislation/Details/sb0778?ys=2026RS"
source_hash: "8cf325508ecdbe9edac924f7ec2711b1651a9ee5b2b4ac3c76dfbbb206244967"
vintage: "2026-07-01"
source_snapshot: "https://data.openstates.org/daily/2026-07-01/public.pgdump"
retrieved_at: "2026-07-06"
confidence: "reported"
tags: ["legislation", "bill", "us-md"]
---

# Maryland SB 778 (2026) — Clinical Research Pharmacies and Clinical Trials - Permits and Ownership

## Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

1. **Chapter - Clinical Research Pharmacies and Clinical Trials - Permits and Ownership** (committee substitute) — [source](http://mgaleg.maryland.gov/2026RS/Chapters_noln/CH_206_sb0778t.pdf)
2. **First - Clinical Research Pharmacies and Clinical Trials - Permits, Ownership, and Definition of Practice of Medicine** (committee substitute) — [source](http://mgaleg.maryland.gov/2026RS/bills/sb/sb0778f.pdf)
3. **Third - Clinical Research Pharmacies and Clinical Trials - Permits and Ownership** (committee substitute) — [source](http://mgaleg.maryland.gov/2026RS/bills/sb/sb0778t.pdf)

## Votes

- On Third Reading — **129–6** (pass) · lower
- On Third Reading — **42–0** (pass) · upper

## Sponsors

- Feldman — primary (person)

## Timeline

The legislative action history — every referral, reading, and vote.

- **2026-02-06** First Reading Finance `referral-committee`
- **2026-02-12** Hearing 3/03 at 1:00 p.m.
- **2026-03-19** Favorable with Amendments Report by Finance `committee-passage-favorable`
- **2026-03-19** Favorable with Amendments { `committee-passage-favorable`
- **2026-03-19** Second Reading Passed with Amendments
- **2026-03-20** Third Reading Passed `passage`
- **2026-03-21** Referred Health `referral-committee`
- **2026-03-25** Hearing 4/02 at 1:00 p.m.
- **2026-04-11** Favorable Report by Health `committee-passage-favorable`
- **2026-04-11** Favorable Adopted Second Reading Passed `committee-passage-favorable`
- **2026-04-13** Third Reading Passed `passage`
- **2026-04-13** Returned Passed
- **2026-04-28** Approved by the Governor - Chapter 206 `executive-signature`

## Source

OpenStates / OpenCivicData bulk snapshot [2026-07-01](https://data.openstates.org/daily/2026-07-01/public.pgdump); origin `ocd-bill/498ecf74-d8cc-4270-abfc-89c1610eec22`. Confidence: reported (aggregated from official Maryland legislature records).